NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence company transforming clinical trials with AI-powered precision ...

The program is designed and delivered by IIT Bombay faculty, with Great Learning as the EdTech partner. The program can be completed in 1 year.

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Forbes contributors publish independent expert analyses and insights. Jodie Cook covers AI and founder-led growth for business owners. LinkedIn's algorithm has changed, making old tactics obsolete.

While the creation of this new entity marks a big step toward avoiding a U.S. ban, as well as easing trade and tech-related tensions between Washington and Beijing, there is still uncertainty ...

Understanding MDS risk classification enhances patient care, focusing on tailored therapies and improving quality of life through effective treatment strategies. In clinical practice, patients with ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...

Abstract: In this paper, firstly, we study decoding of a general class of twisted generalized Reed-Solomon (TGRS) codes and provide a precise characterization of the key equation for TGRS codes and ...

Last year, fashion publications wrote extensively about the impact of the algorithm on personal style. (Vogue Business included.) In last year’s fashion conversation, ‘the algorithm’ surpassed its ...

Five people living with myelodysplastic syndromes (MDS) or in survivorship talk about their experiences with this serious and commonly misunderstood group of conditions. Myelodysplastic syndromes (MDS ...